Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
2016-2020 | 289 | 40 | 13.8 | 160 | 55.4 | 67 | 23.2 | 17 | 5.9 | 5 | 1.7 |
2015-2019 | 276 | 39 | 14.1 | 144 | 52.2 | 66 | 23.9 | 20 | 7.2 | 7 | 2.5 |
2014-2018 | 265 | 39 | 14.7 | 134 | 50.6 | 64 | 24.2 | 19 | 7.2 | 9 | 3.4 |
2013-2017 | 260 | 43 | 16.5 | 126 | 48.5 | 62 | 23.8 | 19 | 7.3 | 10 | 3.8 |
2012-2016 | 264 | 48 | 18.2 | 124 | 47.0 | 65 | 24.6 | 17 | 6.4 | 10 | 3.8 |
2011-2015 | 236 | 43 | 18.2 | 114 | 48.3 | 56 | 23.7 | 14 | 5.9 | 9 | 3.8 |
2010-2014 | 231 | 46 | 19.9 | 108 | 46.8 | 55 | 23.8 | 15 | 6.5 | 7 | 3.0 |
2009-2013 | 239 | 50 | 20.9 | 117 | 49.0 | 52 | 21.8 | 14 | 5.9 | 6 | 2.5 |
2008-2012 | 237 | 47 | 19.8 | 117 | 49.4 | 53 | 22.4 | 15 | 6.3 | 5 | 2.1 |
2007-2011 | 233 | 46 | 19.7 | 116 | 49.8 | 49 | 21.0 | 16 | 6.9 | 6 | 2.6 |
2006-2010 | 234 | 43 | 18.4 | 118 | 50.4 | 53 | 22.6 | 15 | 6.4 | 5 | 2.1 |
2005-2009 | 235 | 39 | 16.6 | 127 | 54.0 | 50 | 21.3 | 13 | 5.5 | 6 | 2.6 |
2004-2008 | 224 | 27 | 12.1 | 124 | 55.4 | 50 | 22.3 | 13 | 5.8 | 10 | 4.5 |
2003-2007 | 223 | 30 | 13.5 | 122 | 54.7 | 51 | 22.9 | 8 | 3.6 | 12 | 5.4 |
2002-2006 | 242 | 33 | 13.6 | 126 | 52.1 | 63 | 26.0 | 7 | 2.9 | 13 | 5.4 |
2001-2005 | 241 | 33 | 13.7 | 127 | 52.7 | 61 | 25.3 | 5 | 2.1 | 15 | 6.2 |
2000-2004 | 253 | 37 | 14.6 | 126 | 49.8 | 68 | 26.9 | 6 | 2.4 | 16 | 6.3 |
1999-2003 | 261 | 44 | 16.9 | 131 | 50.2 | 67 | 25.7 | 9 | 3.4 | 10 | 3.8 |
1998-2002 | 257 | 39 | 15.2 | 125 | 48.6 | 66 | 25.7 | 13 | 5.1 | 14 | 5.4 |
1997-2001 | 240 | 31 | 12.9 | 121 | 50.4 | 60 | 25.0 | 13 | 5.4 | 15 | 6.3 |
1996-2000 | 241 | 34 | 14.1 | 121 | 50.2 | 56 | 23.2 | 13 | 5.4 | 17 | 7.1 |
1995-1999 | 217 | 28 | 12.9 | 109 | 50.2 | 49 | 22.6 | 12 | 5.5 | 19 | 8.8 |
1994-1998 | 218 | 27 | 12.4 | 101 | 46.3 | 56 | 25.7 | 9 | 4.1 | 25 | 11.5 |
1993-1997 | 220 | 29 | 13.2 | 112 | 50.9 | 50 | 22.7 | 7 | 3.2 | 22 | 10.0 |
1992-1996 | 217 | 28 | 12.9 | 116 | 53.5 | 44 | 20.3 | 7 | 3.2 | 22 | 10.1 |
1991-1995 | 203 | 21 | 10.3 | 106 | 52.2 | 45 | 22.2 | 11 | 5.4 | 20 | 9.9 |
1990-1994 | 223 | 21 | 9.4 | 108 | 48.4 | 54 | 24.2 | 13 | 5.8 | 27 | 12.1 |
1989-1993 | 216 | 17 | 7.9 | 103 | 47.7 | 44 | 20.4 | 17 | 7.9 | 35 | 16.2 |
1988-1992 | 216 | 13 | 6.0 | 90 | 41.7 | 41 | 19.0 | 17 | 7.9 | 55 | 25.5 |
1987-1991 | 210 | 11 | 5.2 | 75 | 35.7 | 40 | 19.0 | 16 | 7.6 | 68 | 32.4 |
1986-1990 | 213 | 12 | 5.6 | 68 | 31.9 | 46 | 21.6 | 14 | 6.6 | 73 | 34.3 |
1985-1989 | 194 | 11 | 5.7 | 67 | 34.5 | 38 | 19.6 | 14 | 7.2 | 64 | 33.0 |
Notes: |
---|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
Last Updated : April 13, 2023 |